0001078782-18-000559.txt : 20180515 0001078782-18-000559.hdr.sgml : 20180515 20180515160248 ACCESSION NUMBER: 0001078782-18-000559 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20180515 DATE AS OF CHANGE: 20180515 EFFECTIVENESS DATE: 20180515 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Zivo Bioscience, Inc. CENTRAL INDEX KEY: 0001101026 STANDARD INDUSTRIAL CLASSIFICATION: FOOD & KINDRED PRODUCTS [2000] IRS NUMBER: 870699977 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-312457 FILM NUMBER: 18836235 BUSINESS ADDRESS: STREET 1: 2804 ORCHARD LAKE ROAD, SUITE 202 CITY: KEEGO HARBOR STATE: MI ZIP: 48320 BUSINESS PHONE: (248) 452 9866 MAIL ADDRESS: STREET 1: 2804 ORCHARD LAKE ROAD, SUITE 202 CITY: KEEGO HARBOR STATE: MI ZIP: 48320 FORMER COMPANY: FORMER CONFORMED NAME: HEALTH ENHANCEMENT PRODUCTS INC DATE OF NAME CHANGE: 20040202 FORMER COMPANY: FORMER CONFORMED NAME: WESTERN GLORY HOLE INC DATE OF NAME CHANGE: 19991215 D 1 primary_doc.xml X0708 D LIVE 0001101026 Zivo Bioscience, Inc. 2804 ORCHARD LAKE ROAD, SUITE 202 KEEGO HARBOR MI MICHIGAN 48320 (248) 452 9866 NEVADA HEALTH ENHANCEMENT PRODUCTS INC WESTERN GLORY HOLE INC Corporation true Philip Marshall Rice II 2804 Orchard Lake Road Suite 202 Keego Harbor MI MICHIGAN 48320 Executive Officer Director Andrew A Dahl 2804 Orchard Lake Road Suite 202 Keego Harbor MI MICHIGAN 48320 Executive Officer Other Health Care No Revenues 06b false true false true true true true false 50000 Cascade Partners BD, LLC 148739 None None 29100 Northwestern Hwy Suite 405 Southfield MI MICHIGAN 48034 UT UTAH IL ILLINOIS NY NEW YORK IN INDIANA CT CONNECTICUT GA GEORGIA MN MINNESOTA WI WISCONSIN AZ ARIZONA MO MISSOURI CA CALIFORNIA LA LOUISIANA ME MAINE WA WASHINGTON NJ NEW JERSEY VA VIRGINIA MI MICHIGAN OH OHIO TX TEXAS CO COLORADO FL FLORIDA MD MARYLAND PA PENNSYLVANIA MA MASSACHUSETTS false 5000000 0 5000000 false 0 350000 true 0 7% to 8% commission of equity and subordinate debt, and 2% of senior debt. Initial warrant for 2,326,504 shares at $.10. Follow on warrant for 1% of total outstanding shares at time of complete funding. 250000 true false Zivo Bioscience, Inc. /s/ Philip M. Rice II Philip M. Rice II Chief Financal Officer 2018-05-15